Selected research
Industry Research
ERBB2 Antibody Industry Research Report 2026
Market perspective
The global ERBB2 Antibody market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the ERBB2 Antibody market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the ERBB2 Antibody market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the ERBB2 Antibody market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of ERBB2 Antibody include Abbiotec, Bio X Cell, Biorbyt, Boster Bio, Everest Biotech, FineTest, Hytest, OriGene Technologies and ProSci, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global ERBB2 Antibody market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to ERBB2 Antibody.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
ERBB2 Antibody Market by Company
Abbiotec
Bio X Cell
Biorbyt
Boster Bio
Everest Biotech
FineTest
Hytest
OriGene Technologies
ProSci
Proteintech
Santa Cruz Biotechnology
Merck
Thermo Fisher Scientific
ERBB2 Antibody Segment by Type
Polyclonal
Monoclonal
ERBB2 Antibody Segment by Application
Immunohistochemistry Paraffin
Immunohistochemistry Frozen
Immunoprecipitation
Enzyme Linked Immunosorbent Assay
Others
ERBB2 Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ERBB2 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ERBB2 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ERBB2 Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of ERBB2 Antibody companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal
- Monoclonal
Applications
- Immunohistochemistry Paraffin
- Immunohistochemistry Frozen
- Immunoprecipitation
- Enzyme Linked Immunosorbent Assay
- Others
Companies covered
- Abbiotec
- Bio X Cell
- Biorbyt
- Boster Bio
- Everest Biotech
- FineTest
- Hytest
- OriGene Technologies
- ProSci
- Proteintech
- Santa Cruz Biotechnology
- Merck
- Thermo Fisher Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 ERBB2 Antibody by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Polyclonal
- 2.2.3 Monoclonal
- 2.3 ERBB2 Antibody by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Immunohistochemistry Paraffin
- 2.3.3 Immunohistochemistry Frozen
- 2.3.4 Immunoprecipitation
- 2.3.5 Enzyme Linked Immunosorbent Assay
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 ERBB2 Antibody Breakdown Data by Type
- 3.1 Global ERBB2 Antibody Historic Market Size by Type (2021-2026)
- 3.2 Global ERBB2 Antibody Forecasted Market Size by Type (2027-2032)
4 ERBB2 Antibody Breakdown Data by Application
- 4.1 Global ERBB2 Antibody Historic Market Size by Application (2021-2026)
- 4.2 Global ERBB2 Antibody Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global ERBB2 Antibody Market Perspective (2021-2032)
- 5.2 Global ERBB2 Antibody Growth Trends by Region
- 5.2.1 Global ERBB2 Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 ERBB2 Antibody Historic Market Size by Region (2021-2026)
- 5.2.3 ERBB2 Antibody Forecasted Market Size by Region (2027-2032)
- 5.3 ERBB2 Antibody Market Dynamics
- 5.3.1 ERBB2 Antibody Industry Trends
- 5.3.2 ERBB2 Antibody Market Drivers
- 5.3.3 ERBB2 Antibody Market Challenges
- 5.3.4 ERBB2 Antibody Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top ERBB2 Antibody Players by Revenue
- 6.1.1 Global Top ERBB2 Antibody Players by Revenue (2021-2026)
- 6.1.2 Global ERBB2 Antibody Revenue Market Share by Players (2021-2026)
- 6.2 Global ERBB2 Antibody Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of ERBB2 Antibody Head Office and Area Served
- 6.4 Global ERBB2 Antibody Players, Product Type & Application
- 6.5 Global ERBB2 Antibody Manufacturers Established Date
- 6.6 Global ERBB2 Antibody Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America ERBB2 Antibody Market Size (2021-2032)
- 7.2 North America ERBB2 Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America ERBB2 Antibody Market Size by Country (2021-2026)
- 7.4 North America ERBB2 Antibody Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe ERBB2 Antibody Market Size (2021-2032)
- 8.2 Europe ERBB2 Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe ERBB2 Antibody Market Size by Country (2021-2026)
- 8.4 Europe ERBB2 Antibody Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific ERBB2 Antibody Market Size (2021-2032)
- 9.2 Asia-Pacific ERBB2 Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific ERBB2 Antibody Market Size by Country (2021-2026)
- 9.4 Asia-Pacific ERBB2 Antibody Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America ERBB2 Antibody Market Size (2021-2032)
- 10.2 South America ERBB2 Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America ERBB2 Antibody Market Size by Country (2021-2026)
- 10.4 South America ERBB2 Antibody Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa ERBB2 Antibody Market Size (2021-2032)
- 11.2 Middle East & Africa ERBB2 Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa ERBB2 Antibody Market Size by Country (2021-2026)
- 11.4 Middle East & Africa ERBB2 Antibody Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbiotec
- 12.1.1 Abbiotec Company Information
- 12.1.2 Abbiotec Business Overview
- 12.1.3 Abbiotec Revenue in ERBB2 Antibody Business (2021-2026)
- 12.1.4 Abbiotec ERBB2 Antibody Product Portfolio
- 12.1.5 Abbiotec Recent Developments
- 12.2 Bio X Cell
- 12.2.1 Bio X Cell Company Information
- 12.2.2 Bio X Cell Business Overview
- 12.2.3 Bio X Cell Revenue in ERBB2 Antibody Business (2021-2026)
- 12.2.4 Bio X Cell ERBB2 Antibody Product Portfolio
- 12.2.5 Bio X Cell Recent Developments
- 12.3 Biorbyt
- 12.3.1 Biorbyt Company Information
- 12.3.2 Biorbyt Business Overview
- 12.3.3 Biorbyt Revenue in ERBB2 Antibody Business (2021-2026)
- 12.3.4 Biorbyt ERBB2 Antibody Product Portfolio
- 12.3.5 Biorbyt Recent Developments
- 12.4 Boster Bio
- 12.4.1 Boster Bio Company Information
- 12.4.2 Boster Bio Business Overview
- 12.4.3 Boster Bio Revenue in ERBB2 Antibody Business (2021-2026)
- 12.4.4 Boster Bio ERBB2 Antibody Product Portfolio
- 12.4.5 Boster Bio Recent Developments
- 12.5 Everest Biotech
- 12.5.1 Everest Biotech Company Information
- 12.5.2 Everest Biotech Business Overview
- 12.5.3 Everest Biotech Revenue in ERBB2 Antibody Business (2021-2026)
- 12.5.4 Everest Biotech ERBB2 Antibody Product Portfolio
- 12.5.5 Everest Biotech Recent Developments
- 12.6 FineTest
- 12.6.1 FineTest Company Information
- 12.6.2 FineTest Business Overview
- 12.6.3 FineTest Revenue in ERBB2 Antibody Business (2021-2026)
- 12.6.4 FineTest ERBB2 Antibody Product Portfolio
- 12.6.5 FineTest Recent Developments
- 12.7 Hytest
- 12.7.1 Hytest Company Information
- 12.7.2 Hytest Business Overview
- 12.7.3 Hytest Revenue in ERBB2 Antibody Business (2021-2026)
- 12.7.4 Hytest ERBB2 Antibody Product Portfolio
- 12.7.5 Hytest Recent Developments
- 12.8 OriGene Technologies
- 12.8.1 OriGene Technologies Company Information
- 12.8.2 OriGene Technologies Business Overview
- 12.8.3 OriGene Technologies Revenue in ERBB2 Antibody Business (2021-2026)
- 12.8.4 OriGene Technologies ERBB2 Antibody Product Portfolio
- 12.8.5 OriGene Technologies Recent Developments
- 12.9 ProSci
- 12.9.1 ProSci Company Information
- 12.9.2 ProSci Business Overview
- 12.9.3 ProSci Revenue in ERBB2 Antibody Business (2021-2026)
- 12.9.4 ProSci ERBB2 Antibody Product Portfolio
- 12.9.5 ProSci Recent Developments
- 12.10 Proteintech
- 12.10.1 Proteintech Company Information
- 12.10.2 Proteintech Business Overview
- 12.10.3 Proteintech Revenue in ERBB2 Antibody Business (2021-2026)
- 12.10.4 Proteintech ERBB2 Antibody Product Portfolio
- 12.10.5 Proteintech Recent Developments
- 12.11 Santa Cruz Biotechnology
- 12.11.1 Santa Cruz Biotechnology Company Information
- 12.11.2 Santa Cruz Biotechnology Business Overview
- 12.11.3 Santa Cruz Biotechnology Revenue in ERBB2 Antibody Business (2021-2026)
- 12.11.4 Santa Cruz Biotechnology ERBB2 Antibody Product Portfolio
- 12.11.5 Santa Cruz Biotechnology Recent Developments
- 12.12 Merck
- 12.12.1 Merck Company Information
- 12.12.2 Merck Business Overview
- 12.12.3 Merck Revenue in ERBB2 Antibody Business (2021-2026)
- 12.12.4 Merck ERBB2 Antibody Product Portfolio
- 12.12.5 Merck Recent Developments
- 12.13 Thermo Fisher Scientific
- 12.13.1 Thermo Fisher Scientific Company Information
- 12.13.2 Thermo Fisher Scientific Business Overview
- 12.13.3 Thermo Fisher Scientific Revenue in ERBB2 Antibody Business (2021-2026)
- 12.13.4 Thermo Fisher Scientific ERBB2 Antibody Product Portfolio
- 12.13.5 Thermo Fisher Scientific Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst